Kalyug Capital

Research Reports

Deep-dive investment theses on the secular dislocations Kalyug Capital tracks. Each report maps a theme to its structural winners.

2026 Reports
GH BPC TB4 IGF NAD COL OPTIMIZE ▲
Research Report · 2026

Lookmaxxing Economics
Top 5 stocks riding the intersection of vanity, longevity, and pharmaceutical permissiveness.

The body is no longer something you're born with and accept. It's a project. GLP-1 drugs broke the psychological barrier — everything downstream follows. We mapped the structural winners before the crowd figures it out.

$NVO  ·  $LLY  ·  $ABBV  ·  $INMD  ·  $HIMS
Read the Report →
MedSpa  ·  Aesthetics  ·  Peptide Biotech  ·  GLP-1